Alfaxalone:: Effect of temperature on complexation with 2-hydroxypropyl-β-cyclodextrin

被引:0
作者
Peeters, J [1 ]
Neeskens, P [1 ]
Adriaensen, J [1 ]
Brewster, M [1 ]
机构
[1] Johnson & Johnson Res & Dev, Dept Drug Delivery Res, Drug Evaluat, CM&C, B-2340 Beerse, Belgium
关键词
alfaxalone; complexation; 2-hydroxypropyl-beta-cyclodextrin (HP beta CD); solubility;
D O I
10.1023/A:1023080832018
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Phase solubility analysis is used to investigate the complex formation of alfaxalone with various cyclodextrins (2-hydroxypropyl-beta-cyclodextrine [HPBCD], beta-cyclodextrin [BCD] and 2-hydroxypropyl-gamma-cyclodextrin [HPGCD]). The complexation with HPBCD was studied in more detail by looking at the effect of temperature on the stability constants using phase solubility analysis. HPLC-analysis was used to measure the dissolved amount of alfaxalone. The solubility of alfaxalone increases linearly with increasing concentration of cyclodextrin, suggesting the formation of a 1 : 1 complex. For the parent BCD the complex starts precipitating out of solution when the solubilizer concentration exceeds 0.25% making the unsubstituted BCD less useful for the preparation of solutions of alfaxalone. Substituted cyclodextrins do not form insoluble complexes with alfaxalone. The complexation constant for BCD and HPBCD are comparable in magnitude, but for HPGCD, the constant is substantially lower. The effect of temperature on the complexation constant was also studied at elevated temperature. Increasing the temperature results in an increased S-0 (solubility without HPBCD) and a decrease in the value of the complexation constant. The net effect results in minor changes of the solubility of alfaxalone as a function of temperature. Based on regression analysis, the change in enthalpy for complex formation between alfaxalone and HPBCD is calculated as -4610 cal/mol. The results indicate that substituted cyclodextrins are useful in the preparation of solutions of alfaxalone. Since 1 : 1 complexes are formed there is no theoretical danger for precipitation on dilution, e. g., after injection.
引用
收藏
页码:75 / 77
页数:3
相关论文
共 8 条
[1]  
Badawy SIF, 1996, INT J PHARM, V128, P45
[2]  
BREWSTER ME, 1989, J PARENT SCI TECHN, V43, P262
[3]  
CAMBELL D, 1971, BRIT J ANAESTH, V43, P14
[4]   A NONSURFACTANT FORMULATION FOR ALFAXALONE BASED ON AN AMORPHOUS CYCLODEXTRIN - ACTIVITY STUDIES IN RATS AND DOGS [J].
ESTES, KS ;
BREWSTER, ME ;
WEBB, AI ;
BODOR, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 65 (1-2) :101-107
[5]  
Higuchi T., 1965, Interscience, New York, V4, P117
[6]  
MARTIN A, 1993, PHYSICAL PHARM, P274
[7]  
SZEJTLI J, 1982, CYCLODEXTRINS THEIR, P103
[8]   ASSESSMENT OF THE ALLERGENIC POTENTIAL OF ALTHESIN AND ITS CONSTITUENTS [J].
TACHON, P ;
DESCOTES, J ;
LASCHILOQUERIE, A ;
GUILLOT, JP ;
EVREUX, JC .
BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (08) :715-717